Controlled release of platelet-derived growth factor-BB from chondroitin sulfate-chitosan sponge for guided bone regeneration

J Control Release. 2000 Jul 3;67(2-3):385-94. doi: 10.1016/s0168-3659(00)00232-7.

Abstract

Platelet-derived growth factor-BB (PDGF-BB) releasing porous chondroitin-4-sulfate (CS)-chitosan sponge was designed with an aim of controlling growth factor delivery in order to improve bone formation. Porous CS-chitosan sponge was fabricated by freeze drying and crosslinking aqueous CS-chitosan solution. PDGF-BB was incorporated into the CS-chitosan sponge by soaking CS-chitosan sponge into the PDGF-BB solution. CS-chitosan sponge retained a porous structure with a 150-200-microm pore diameter that was suitable for cellular migration and osteoid ingrowth. Release rate of PDGF-BB could be controlled by varying the composition of CS in the sponge or initial loading content of PDGF-BB. CS-chitosan sponge induced increased osteoblast migration and proliferation as compared with chitosan sponge alone. Furthermore, the release of PDGF-BB from CS-chitosan sponge significantly enhanced osteoblast proliferation. These results suggest that PDGF-BB-releasing CS-chitosan sponge may be beneficial to enhance bone cell adaptation and regenerative potential when applied in wound sites.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Becaplermin
  • Bone Regeneration / drug effects*
  • Cells, Cultured
  • Chemotaxis / drug effects
  • Chitin / analogs & derivatives*
  • Chitin / chemistry
  • Chitosan
  • Chondroitin Sulfates / chemistry*
  • Delayed-Action Preparations
  • Excipients
  • Fibroblasts
  • Gingiva / cytology
  • Kinetics
  • Microscopy, Electron, Scanning
  • Osteoblasts / drug effects
  • Platelet-Derived Growth Factor / administration & dosage*
  • Platelet-Derived Growth Factor / pharmacology
  • Porosity
  • Proto-Oncogene Proteins c-sis
  • Rats
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / pharmacology
  • Skull / cytology

Substances

  • Delayed-Action Preparations
  • Excipients
  • Platelet-Derived Growth Factor
  • Proto-Oncogene Proteins c-sis
  • Recombinant Proteins
  • Chitin
  • Becaplermin
  • Chondroitin Sulfates
  • Chitosan